PharmaShots | Incisive News in 3 Shots

Subscribe Now

Advanced Renal

Merck & Co's Keytruda (pembrolizumab) Receives Health Canada's Approval as 1L Treatment for Advanced Renal Cell Carcinoma

Merck & Co's Keytruda (pembrolizumab) Receives Health Canada's Approval as 1L Treatment for Advanced Renal Cell Carcinoma

January 23, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us